An overview of the Pediatric Endocrine Society's Ethics Symposium held in April 2015 at the annual meeting of the Pediatric Academic Societies is provided by the panel moderators with a summary of efforts by international athletic governing bodies over several decades to ‘verify' the eligibility of athletes to compete in female only events, culminating in the hyperandrogenism policies that were the focus of the panel debate. This history was extensively reviewed in the symposium's opening presentation by Alan Rogol, in collaboration with Lindsay Pieper. Two sharply divergent views were then conveyed. David Allen's, in support, is provided in his article which follows. The opposing case, provided by Katrina Karkazis, is extensively summarized herein and reflected in her Science essay with Rebecca Jordan-Young which appeared shortly after the meeting. The subsequent ruling by the international Court of Arbitration for Sport to suspend the hyperandrogenism rule is noted with some speculation regarding the implications if it is upheld.

Keywords:
Disorders of sex development, International Association of Athletic Federations, International Olympic Committee, Hyperandrogenism, Testosterone, Sex/gender verification
1.
Rupert JT: Genitals to genes: the history and biology of gender verification in the Olympics. Can Bull Med Hist 2011;28:339-365.
2.
Martinez-Patino MJ: Personal account. A woman tried and tested. Lancet 2005;366:S38.
3.
Ljungqvist A, Simpson JL: Medical examination for health of all athletes replacing the need for gender verification in competitive sports. The International Amateur Athletic Federation plan. JAMA 1992;267:850-852.
4.
Wilson JD: Sex testing in international athletics. A small step forward (editorial). JAMA 1992;267:853.
5.
Genel M, Ljungqvist A: Gender verification of female athletes. Lancet 2005;366:S41.
6.
Dickinson BD, Genel M, Turner PL, Robinowitz CB, Woods GL: Gender verification of female Olympic athletes. Med Sci Sports Exerc 2002;34:1539-1542.
7.
International Association of Athletic Federations 2011 IAAF regulations governing eligibility of females with hyperandrogenism to compete in women's competition. http://www.iaaf.org/mm/Document/AboutIAAF/Publications/05/98/78/20110430054216_httpostedfile_HARegulations(Final)-Appendices-AMG-30.04.2011_24299.pdf (accessed September 21, 2015).
8.
International Olympic Committee 2012 IOC regulations on female hyperandrogenism: games of the XXX Olympiad in London. 2012. http://www.olympic.org/Documents/Commissions_PDFfiles/Medical_commission/2012-06-22-IOC-Regulations-on-Female-Hyperandrogenism-2ng.pdf (accessed September 21, 2015).
9.
Murray TM: Making sense of fairness in sports. Hastings Cent Rep 2010;40:13-15.
10.
Karkazis K, Jordan-Young R, Davis G, Camporesi S: Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes. Am J Bioeth 2012;12:3-16.
11.
Karkazis K, Jordan-Young R: The Harrison Bergeron Olympics. Am J Bioeth 2013;13:66-69.
12.
Bermon S, Ritzen M, Hirschberg AL, Murray TH: Are the new policies on hyperandrogenism in elite female athletes really out of bounds? Response to ‘Out of bounds'? A critique of the new policies on hyperandrogenism in elite female athletes'. Am J Bioeth 2013;13:63-65.
13.
Jordan-Young R, Sonksen P, Karkazis K: Sex, health and athletes. BMJ 2014;348:g2926.
14.
Karkazis K, Jordan-Young R: Debating a testosterone ‘sex gap'. Policies unfairly exclude some women athletes from competition. Science 2015;348:858-860.
15.
Healy ML, Gibney J, Pentecost C, Wheeler MJ, Sonksen PH: Endocrine profiles in 693 elite athletes in the postcompetition setting. Clin Endocrinol 2014;81:294-305.
16.
Bermon S, Garnier PY, Hirschberg AL, Robinson N, Giraud S, Nicoli R, Baume N, Saugy M, Fenichel P, Bruce SJ, Henry H, Dolle G, Ritzen M: Serum androgen levels in elite female athletes. J Clin Endocrinol Metab 2014;99:4328-4335.
17.
Fenichel P, Paris F, Philibert P, Hieronimus S, Gaspari L, Kurzenne J-V, Chevallier P, Bermon S, Chevalier N, Sultan C: Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. J Clin Endocrinol Metab 2013;98:E1055-E1059.
18.
International Olympic Committee: Factsheet. Women in the Olympic Movement. Update May 2014. http://www.olympic.org/Documents_Factsheets/Women-in-Olympic-Movement.pdf (accessed September 21, 2015).
19.
Ferguson-Smith MA, Bavington LD: Natural selection for genetic variants in sport: the role of Y chromosome genes in elite female athletes with 46,XY DSD. Sports Med 2014;44:1629-1634.
20.
Ljungqvist A, Genel M: Transsexual athletes - when is competition fair? Lancet 2005;366:S42-S43.
21.
Gooren LJ: Olympic sports and transsexuals. Asian J Androl 2008;10:427-432.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.